Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 16, 2024, titled "OneSource, the Group s Spec Pharm CDMO, receives equity commitments of INR 8,010 mn (USD 95 mn) from marquee investors at a pre-money equity valuation of USD 1.65 bn".